[Management of adult bronchiectasis].
Non-cystic fibrosis bronchiectasis has been the subject of renewed interest over recent years. It is usually part of the evolutionary process of many infectious, autoimmune, genetic, developmental or allergic diseases. Its presentation and prognosis are heterogeneous and it causes significant morbidity and mortality with a real impact on the health care system. Thanks to increasingly available guidelines, it is now possible to define the optimal management that will include various therapeutic objectives : airway clearance, prevention and eradication of bacterial colonization, reduction of airway inflammation and exacerbations and improvement of quality of life.